A trial will look at whether a naturally occurring compound, known as angiotensin 1-7, relieves cognitive deficits after heart bypass. The UA collaborators include a cardiologist, a physiologist and a psychologist.

Continue reading→

The Arizona Bioindustry Association will honor Avery Therapeutics Inc. with an AZBio Fast Lane Award at the 2017 AZBio Awards.  Arizona life science and business leaders as well as guests from across the country will be on hand to applaud the Avery Therapeutics team for their progress in developing a novel lifesaving medical device to address heart failure.Continue reading→

Tucson, Ariz. – The University of Arizona has licensed a new non-penetrating sunscreen to MexiAloe Laboratorios, S.A. de C.V., a subsidiary of Novamex.Continue reading→

CSL Behring, has entered  into a deal to buy Calimmune Inc. for $91 million. The deal also includes the potential for Calimmune to earn additional performance based milestone payments of up to $325 million over a period currently anticipated to be around eight years or more following the closing of the transaction. The transaction is expected to close within the next two weeks.Continue reading→

The Arizona Bioindustry Association will honor NuvOx Pharma with an AZBio Fast Lane Award at the 2017 AZBio Awards.  Continue reading→

The center will use the money to accelerate development of a Valley fever vaccine for dogs that one day may lead to a successful human vaccine. A California-based biotech company and Colorado State University have joined the center in the effort.Continue reading→

According to Paul Coleman, an Alzheimer’s researcher at the ASU-Banner Neurodegenerative Disease Research Center (NDRC), one of the greatest difficulties plaguing efforts to find effective treatments for Alzheimer’s is the enormous lag between the disease’s inception and the appearance of clinical symptoms.Continue reading→